Plain-English translation of NCT04567771 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After surgery for cervical or endometrial cancer, patients need radiation therapy to reduce the risk of cancer returning. This trial compares two radiation therapy approaches — proton therapy and intensity-modulated radiation therapy (IMRT) — to see which one causes fewer side effects like bowel and bladder problems, while maintaining or improving how patients feel and their quality of life.
Radiation therapy can damage healthy tissue near the cancer site, causing side effects like digestive problems and urinary issues. This trial exists to determine whether proton therapy, a newer approach, can deliver radiation more precisely to the cancer while sparing healthy organs, making treatment easier for patients to tolerate.
You will receive either proton therapy or intensity-modulated radiation therapy as part of your standard cancer care. Throughout your treatment and for up to three years afterward, you will complete brief questionnaires (10–15 minutes each) about any side effects you experience and how the treatment affects your daily life and well-being. These surveys happen at the start of radiation, at the end of treatment, and then at follow-up visits at one month, one year, and three years after radiation ends.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States